These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34437568)

  • 21. Myocardium injury biomarkers predict prognosis of critically ill coronavirus disease 2019 (COVID-19) patients.
    Cao L; Zhang S; Luo X; Wang E; Bai Y; Li Z; Li F; Ma J; Liu H
    Ann Palliat Med; 2020 Nov; 9(6):4156-4165. PubMed ID: 33302676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
    Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
    Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of Risk Factors for Thromboembolic Events in 88 Patients with COVID-19 Pneumonia in Wuhan, China: A Retrospective Descriptive Report.
    Wang W; Sun Q; Bao Y; Liang M; Meng Q; Chen H; Li J; Wang H; Li H; Shi Y; Li Z; Wang X; Zhao S; Wang H; Xiao J; Chen L; Zheng Y; Wang D; Han K
    Med Sci Monit; 2021 Apr; 27():e929708. PubMed ID: 33839733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
    Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
    J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
    Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
    In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.
    Ramadori G
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 29. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.
    Eriksson O; Hultström M; Persson B; Lipcsey M; Ekdahl KN; Nilsson B; Frithiof R
    Thromb Haemost; 2020 Dec; 120(12):1720-1724. PubMed ID: 32871607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.
    Souza PR; Marques RM; Gomez EA; Colas RA; De Matteis R; Zak A; Patel M; Collier DJ; Dalli J
    Circ Res; 2020 Jan; 126(1):75-90. PubMed ID: 31829100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19 : A Retrospective Study.
    Fu Y; Li Y; Guo E; He L; Liu J; Yang B; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Wu X; Lu F; You L; Qin T; Wang C; Li K; Wu P; Ma D; Sun C; Chen G
    Ann Intern Med; 2021 Apr; 174(4):453-461. PubMed ID: 33284684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DVT incidence and risk factors in critically ill patients with COVID-19.
    Chen S; Zhang D; Zheng T; Yu Y; Jiang J
    J Thromb Thrombolysis; 2021 Jan; 51(1):33-39. PubMed ID: 32607652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
    Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
    Front Immunol; 2021; 12():664209. PubMed ID: 34054832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China.
    Ma S; Lai X; Chen Z; Tu S; Qin K
    Int J Infect Dis; 2020 Jul; 96():683-687. PubMed ID: 32470606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients.
    Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
    Tabatabai A; Rabin J; Menaker J; Madathil R; Galvagno S; Menne A; Chow JH; Grazioli A; Herr D; Tanaka K; Scalea T; Mazzeffi M
    A A Pract; 2020 May; 14(7):e01236. PubMed ID: 32539272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.